Twin Focus Capital Partners LLC Sells 8,000 Shares of Quanterix Co. (NASDAQ:QTRX)

Twin Focus Capital Partners LLC decreased its holdings in shares of Quanterix Co. (NASDAQ:QTRX) by 40.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 12,000 shares of the company’s stock after selling 8,000 shares during the period. Twin Focus Capital Partners LLC’s holdings in Quanterix were worth $328,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. AJOVista LLC bought a new stake in Quanterix during the 4th quarter valued at $81,000. DekaBank Deutsche Girozentrale purchased a new stake in shares of Quanterix during the 3rd quarter valued at $125,000. Picton Mahoney Asset Management purchased a new stake in shares of Quanterix during the 4th quarter valued at $139,000. Quest Partners LLC purchased a new stake in shares of Quanterix during the 4th quarter valued at $240,000. Finally, Los Angeles Capital Management LLC purchased a new stake in shares of Quanterix during the 4th quarter valued at $285,000. Institutional investors own 86.48% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on QTRX. Canaccord Genuity Group decreased their price objective on Quanterix from $32.00 to $25.00 and set a “buy” rating for the company in a report on Monday, April 29th. Scotiabank increased their price objective on Quanterix from $30.00 to $32.00 and gave the company a “sector outperform” rating in a report on Monday, March 4th. Five equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus price target of $30.60.

Quanterix Stock Performance

QTRX stock traded down $1.20 during midday trading on Friday, reaching $13.32. The stock had a trading volume of 1,089,156 shares, compared to its average volume of 414,697. The stock has a market cap of $509.76 million, a PE ratio of -13.88 and a beta of 1.50. The firm has a fifty day simple moving average of $16.81 and a two-hundred day simple moving average of $22.01. Quanterix Co. has a 52-week low of $13.09 and a 52-week high of $29.70.

Quanterix (NASDAQ:QTRX) last issued its earnings results on Tuesday, May 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.07. The company had revenue of $32.07 million during the quarter, compared to analyst estimates of $31.72 million. Quanterix had a negative return on equity of 10.39% and a negative net margin of 28.82%. On average, sell-side analysts predict that Quanterix Co. will post -0.86 EPS for the current fiscal year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.